Successful Retreatment With ADOC Chemotherapy in Relapsed Thymic Carcinoma: Experiences in Two Cases

The optimal second-line chemotherapeutic regimen for thymic carcinoma remains uncertain and predictive factors for the response have not been identified. We encountered two cases of relapsed thymic carcinoma with recurrence 1.5 and 8 years after initial response to cisplatin/doxorubicin/vincristine/...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomura, Yayoi, Koizumi, Tomonobu, Kitaguchi, Akihiro, Horiuchi, Toshimichi, Kanda, Shintarou, Yamamoto, Hiroshi, Hanaoka, Masayuki, Kubo, Keishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649833/
https://www.ncbi.nlm.nih.gov/pubmed/29147275
http://dx.doi.org/10.4021/wjon435w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649833/
https://www.ncbi.nlm.nih.gov/pubmed/29147275
http://dx.doi.org/10.4021/wjon435w

Ejemplares similares